Ulutas, HakkiYekeler, ErdalSak, Zafer Hasan AliDoru, IhsanKuzucu, Akin2024-08-042024-08-0420122213-0071https://doi.org/10.1016/j.rmedc.2011.08.005https://hdl.handle.net/11616/95679Pneumonia and parapneumonic complicated effusion during pregnancy is uncommon but poses potentially serious risks to both mother and fetus. Enzymatic debridement of the pleural cavity with fibrinolytic agents is a noninvasive option that can facilitate drainage and prevent the need for surgery. Herein, we describe the cases of two pregnant women with parapneumonic empyema who were successfully treated with intrapleural fibrinolytic therapy. (C) 2011 Elsevier Ltd.eninfo:eu-repo/semantics/openAccessIntrapleural fibrinolytic therapyParapneumonic empyemaPregnancyFibrinolytic therapy for parapneumonic empyema during pregnancyArticle555582605770910.1016/j.rmedc.2011.08.0052-s2.0-84862018265Q3WOS:000217195500020N/A